Free Trial

Two Sigma Advisers LP Buys 16,800 Shares of Afya Limited (NASDAQ:AFYA)

Afya logo with Consumer Discretionary background

Two Sigma Advisers LP increased its position in shares of Afya Limited (NASDAQ:AFYA - Free Report) by 27.2% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 78,600 shares of the company's stock after purchasing an additional 16,800 shares during the quarter. Two Sigma Advisers LP owned approximately 0.08% of Afya worth $1,248,000 as of its most recent filing with the SEC.

Other large investors have also recently made changes to their positions in the company. Blue Trust Inc. boosted its stake in shares of Afya by 296.9% in the fourth quarter. Blue Trust Inc. now owns 2,072 shares of the company's stock valued at $35,000 after purchasing an additional 1,550 shares during the period. Tower Research Capital LLC TRC raised its holdings in Afya by 1,099.7% during the fourth quarter. Tower Research Capital LLC TRC now owns 4,031 shares of the company's stock worth $64,000 after purchasing an additional 3,695 shares in the last quarter. JPMorgan Chase & Co. increased its holdings in shares of Afya by 2,115.9% in the 4th quarter. JPMorgan Chase & Co. now owns 6,670 shares of the company's stock valued at $106,000 after acquiring an additional 6,369 shares during the period. Aquatic Capital Management LLC increased its holdings in shares of Afya by 47.6% in the 4th quarter. Aquatic Capital Management LLC now owns 9,300 shares of the company's stock valued at $148,000 after acquiring an additional 3,000 shares during the period. Finally, Van ECK Associates Corp grew its position in Afya by 41.9% in the 4th quarter. Van ECK Associates Corp now owns 9,677 shares of the company's stock valued at $154,000 after buying an additional 2,856 shares during the last quarter. 88.02% of the stock is currently owned by hedge funds and other institutional investors.

Afya Stock Performance

NASDAQ AFYA traded down $0.46 during trading hours on Tuesday, hitting $18.06. The company had a trading volume of 88,788 shares, compared to its average volume of 125,225. Afya Limited has a fifty-two week low of $14.52 and a fifty-two week high of $19.90. The company has a quick ratio of 1.60, a current ratio of 1.60 and a debt-to-equity ratio of 0.51. The business has a fifty day simple moving average of $18.41 and a 200-day simple moving average of $17.09. The firm has a market cap of $1.69 billion, a P/E ratio of 14.56, a price-to-earnings-growth ratio of 0.29 and a beta of 0.60.

Afya Dividend Announcement

The firm also recently declared a -- dividend, which was paid on Friday, April 4th. Stockholders of record on Wednesday, March 26th were paid a $0.232 dividend. The ex-dividend date of this dividend was Wednesday, March 26th. Afya's payout ratio is 17.42%.

Wall Street Analysts Forecast Growth

Separately, Morgan Stanley lowered shares of Afya from an "equal weight" rating to an "underweight" rating and decreased their target price for the stock from $19.00 to $17.00 in a research report on Tuesday, March 11th. Three research analysts have rated the stock with a sell rating and two have assigned a hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Reduce" and a consensus price target of $17.60.

View Our Latest Analysis on Afya

Afya Company Profile

(Free Report)

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.

Read More

Institutional Ownership by Quarter for Afya (NASDAQ:AFYA)

Should You Invest $1,000 in Afya Right Now?

Before you consider Afya, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Afya wasn't on the list.

While Afya currently has a Strong Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Top 3 Defense Stocks to Profit From $175 Billion Golden Dome
Top 5 Stocks for June: AI Picks That Aren’t NVIDIA
This Unique Robotaxi Play Could Deliver 10X Returns

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines